Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 2/20 | 0.66 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.60 |
| ▸ | ACE | P12821 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29368129 | 0.93 | OPRM1 (0.74) | OPRM1OPRD1 | |
| SCHEMBL29466604 | 0.91 | OPRM1 (0.70) | OPRM1OPRD1 | |
| SCHEMBL29546278 | 0.91 | OPRM1 (0.70) | OPRM1OPRD1 | |
| SCHEMBL13263479 | 0.90 | OPRM1 (0.63) | OPRM1OPRD1 | |
| SCHEMBL31362697 | 0.90 | OPRM1 (0.56) | OPRM1OPRD1ACE | |
| SCHEMBL31332067 | 0.89 | OPRM1 (0.61) | OPRM1OPRD1 | |
| SCHEMBL22413056 | 0.89 | OPRM1 (0.61) | OPRM1OPRD1 | |
| SCHEMBL22413054 | 0.89 | OPRM1 (0.61) | OPRM1OPRD1 | |
| SCHEMBL22413057 | 0.89 | OPRM1 (0.61) | OPRM1OPRD1 | |
| Morphiceptin SCHEMBL30128493 | 0.87 | OPRM1 (0.81) | OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12013392-B2 | Global proteomic screening of random bead arrays using mass spectrometry imaging | AMBERGEN, INC. (US) | 2024-06-18 | — | — | US | disclosed |
| US-20240069013-A1 | GLOBAL PROTEOMIC SCREENING OF RANDOM BEAD ARRAYS USING MASS SPECTROMETRY IMAGING | AMBERGEN, INC. | 2024-02-29 | — | — | US | disclosed |
| US-11846634-B2 | Global proteomic screening of random bead arrays using mass spectrometry imaging | AMBERGEN, INC. (US) | 2023-12-19 | — | — | US | disclosed |